Key Insights

Highlights

Treatment Research

7 treatments under study, led by Chemoradiation

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Phase 1 (1)
Phase 1/2 (1)

Trial Status

Recruiting2

Clinical Trials (2)

Showing 2 of 2 trials
NCT05526924Phase 1Recruiting

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

NCT03556228Phase 1/2Recruiting

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Showing all 2 trials

Research Network

Common Treatments

  • Chemoradiation1
  • Tislelizumab1
  • Fluorouracil1
  • Vmd928 100 Mg Tablet1
  • Vmd928 Tablet And Pembrolizumab 200 Mg1

Active Sponsors

  • University of Chicago1
  • VM Oncology, LLC1

Top Investigators

Related Conditions

  • Head And Neck Carcinoma2
  • Head And Neck Squamous Cell Carcinoma2
  • Head And Neck Squamous Cell Carcinoma Hnscc1
  • Lung Cancer Locally Advanced Or Metastatic1
  • Head And Neck Cancers1

Activity Timeline